跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“nemvaleukin”
全部
16
临床试验
6
药物
1
机构
0
资讯
9
去年
Mural Therapeutics Discontinues Nemvaleukin Program and Cuts 90% of Workforce Following Clinical Setback
去年
Nemvaleukin Alfa Shows Durable Antitumor Activity in Advanced Melanoma and Renal Cell Carcinoma
去年
Nemvaleukin Shows Promising Antitumor Activity in Advanced Solid Tumors
去年
Mural Oncology's Nemvaleukin Trials Progressing, Data Readouts Anticipated in 2025
去年
Mural Oncology Highlights Nemvaleukin Progress and IL-18 Program at Investor Day
去年
Mural Oncology Gears Up for Key Data Readouts of Nemvaleukin in Ovarian Cancer and Melanoma in 2025
去年
Mural Oncology Cuts 90% of Workforce Following Failed Cancer Immunotherapy Trials
去年
Xoma Royalty Acquires Mural Oncology for $35.2-38.8M in Latest Biotech Liquidation Deal
去年
IL-2 Inhibitor Pipeline Expands with 20+ Companies Developing 22+ Therapeutic Candidates